Bugelski PJ - Search Results

1

Humoral response of cynomolgus macaques to human soluble CD4: antibody reactivity restricted to xeno-human determinants.

Truneh A, Frescatore RL, Thiem P, Leary JJ, Rosenberg M, Hanna N, Sweet R, Bugelski PJ. Truneh A, et al. Among authors: bugelski pj. Cell Immunol. 1990 Nov;131(1):98-108. doi: 10.1016/0008-8749(90)90237-l. Cell Immunol. 1990. PMID: 1699675

2

Recombinant human soluble CD4 does not inhibit immune function in cynomolgus monkeys.

Bugelski PJ, Thiem PA, Truneh A, Morgan DG. Bugelski PJ, et al. Toxicol Pathol. 1991;19(4 Pt 2):580-8. doi: 10.1177/019262339101900403. Toxicol Pathol. 1991. PMID: 1840460

3

Soluble recombinant CD4--a potential therapeutic agent for HIV infection.

Rosenberg M, Bugelski PJ, Fong KL, Drutz DJ, Sweet RW, Webb DD. Rosenberg M, et al. Among authors: bugelski pj. Biotherapy. 1990;2(2):107-18. doi: 10.1007/BF02173451. Biotherapy. 1990. PMID: 2205260 Review. No abstract available.

4

Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation.

Hart TK, Truneh A, Bugelski PJ. Hart TK, et al. Among authors: bugelski pj. AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1305-13. doi: 10.1089/aid.1996.12.1305. AIDS Res Hum Retroviruses. 1996. PMID: 8891109

5

Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.

Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR Jr, Leary J, Bugelski PJ. Hart TK, et al. Among authors: bugelski pj. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93. doi: 10.1073/pnas.88.6.2189. Proc Natl Acad Sci U S A. 1991. PMID: 2006155 Free PMC article.

6

Effects of sensitization to dinitrochlorobenzene (DNCB) on clinical pathology parameters and mitogen-mediated blastogenesis in cynomolgus monkeys (Macaca fascicularis).

Bugelski PJ, Thiem PA, Solleveld HA, Morgan DG. Bugelski PJ, et al. Toxicol Pathol. 1990;18(4 Pt 2):643-50. doi: 10.1177/019262339001800423. Toxicol Pathol. 1990. PMID: 2093224

7

Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.

Newman R, Hariharan K, Reff M, Anderson DR, Braslawsky G, Santoro D, Hanna N, Bugelski PJ, Brigham-Burke M, Crysler C, Gagnon RC, Dal Monte P, Doyle ML, Hensley PC, Reddy MP, Sweet RW, Truneh A. Newman R, et al. Among authors: bugelski pj. Clin Immunol. 2001 Feb;98(2):164-74. doi: 10.1006/clim.2000.4975. Clin Immunol. 2001. PMID: 11161972

8

Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.

Bugelski PJ, Herzyk DJ, Rehm S, Harmsen AG, Gore EV, Williams DM, Maleeff BE, Badger AM, Truneh A, O'Brien SR, Macia RA, Wier PJ, Morgan DG, Hart TK. Bugelski PJ, et al. Hum Exp Toxicol. 2000 Apr;19(4):230-43. doi: 10.1191/096032700678815783. Hum Exp Toxicol. 2000. PMID: 10918514

9

An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.

Kirsh R, Goldstein R, Tarloff J, Parris D, Hook J, Hanna N, Bugelski P, Poste G. Kirsh R, et al. J Infect Dis. 1988 Nov;158(5):1065-70. doi: 10.1093/infdis/158.5.1065. J Infect Dis. 1988. PMID: 3183418

10

Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105.685 in the dog.

Thiem PA, Kaplan JM, Bugelski PJ, Ruggieri EV, Badger AM. Thiem PA, et al. Among authors: bugelski pj. Immunopharmacology. 1992 Mar-Apr;23(2):67-74. doi: 10.1016/0162-3109(92)90029-c. Immunopharmacology. 1992. PMID: 1534791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters